If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Platinum Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Uterine Cervical Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2018

A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice

Jazaeri, A. A., Coleman, R., Sood, A. K., Frumovitz, M., Soliman, P. T., Shafer, A., Cutrera, J. J., Klinger, M., Sharafi, S. E., Johnson, C. A. L., Villanueva, V. F., Hinchcliff, E. M., Dickens, A., Cain, K. E., Anderson, J. E., Lu, K. H. & Westin, S. N., Nov 1 2018, In : Gynecologic oncology. 151, 2, p. 374-380 7 p.

Research output: Contribution to journalReview article

Pharmaceutical Preparations
Clinical Trials
1 Citations

Clinical trial methodology in rare gynecologic tumor research: Strategies for success

Brown, J., Naumann, R. W., Brady, W. E., Coleman, R. L., Moore, K. N. & Gershenson, D. M., Jun 1 2018, In : Gynecologic oncology. 149, 3, p. 605-611 7 p.

Research output: Contribution to journalReview article

Clinical Trials
Standard of Care
Sample Size
Ovarian Neoplasms
Stomach Diseases

Defining Survivorship Trajectories Across Patients With Solid Tumors: An Evidence-Based Approach

Dood, R. L., Zhao, Y., Armbruster, S. D., Coleman, R., Tworoger, S., Sood, A. K. & Baggerly, K. A., Nov 1 2018, In : JAMA Oncology. 4, 11, p. 1519-1526 8 p.

Research output: Contribution to journalArticle

Survival Rate
Primary Care Physicians
1 Citations

Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)

Mitamura, T., Pradeep, S., McGuire, M., Wu, S. Y., Ma, S., Hatakeyama, H., Lyons, Y. A., Hisamatsu, T., Noh, K., Villar-Prados, A., Chen, X., Ivan, C., Rodriguez-Aguayo, C., Hu, W., Lopez, G., Coleman, R. & Sood, A. K., Feb 8 2018, In : Oncogene. 37, 6, p. 722-731 10 p.

Research output: Contribution to journalArticle

Vascular Endothelial Growth Factor A
R Factors